<DOC>
	<DOC>NCT01226095</DOC>
	<brief_summary>This is a prospective, multi-center, post-marketing observational study to evaluate the effectiveness and compliance of ibuprofen in a sustained release form in the treatment of Egyptian osteoarthritic patients.</brief_summary>
	<brief_title>Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients</brief_title>
	<detailed_description>This was a prospective, longitudinal, multicenter observational study conducted in a clinical practice setting where the study product was used in osteoarthritis patients as indicated in the approved package insert; the dosing regimen of Brufen retard is 2 tablets as a single dose once daily.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Patients seeking treatment for osteoarthritis and there are clinical or radiological evidence of the disease, Male or female, age â‰¥ 18 Designated to treatment with Ibuprofen in a sustained release form (Brufen Retard) according to the best criterion of the physician and if he decides to treat the patient according to labeled indication and dose for 4 weeks. Patients who have given their written informed consent to participate in the study Patients who are currently taking non steroidal anti inflammatory drugs (NSAIDs), should complete an initial washout phase 10 days depending on the half life of the drug taken Contraindications as described in company core data sheet (CCDS) and specifically Patients with active peptic ulcer Patients who have presented reactions of hypersensitivity (asthma , rhinitis or urticaria ) with ibuprofen or other antiinflammatory non steroids Patients with active cardiovascular disease and those taking aspirin/warfarin for prophylaxis for myocardial infarction (MI) or stroke Patients with moderate to severe renal diseases Patients with moderate to severe hepatic disease Patients with Crohn's disease Patients included currently in another study Women of childbearing potential must not be pregnant Any patients the investigators consider ineligible for this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Pain</keyword>
	<keyword>Morning stiffness</keyword>
</DOC>